logo

LFSC

F/m Emerald Life Sciences Innovation ETF·NASDAQ
--
--(--)
--
--(--)
F/m Emerald Life Sciences Innovation ETF Fundamentals
Assets Under Management
88.62MUSD
Fund Flows (1Y)
16.04MUSD
Dividend Yield (TTM)
--
Discount/Premium to NAV
0.04%
Shares Outstanding
2.70M
Expense Ratio
0.79%
Returns
1-Month
3-Month
YTD
1-Year
3-Year
5-Year
Price Performance
-4.77%-12.38%-4.98%+46.67%+37.17%+37.17%
NAV Total Return
-7.91%-14.11%-7.00%+41.97%-0.05%-0.05%
Ratings

Aime Ratings

No data is currently available

No data is currently available

Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis

Sector

Healthcare

100.00%

Asset

Region

97.24%
2.76%

Category

Ratio

North America

97.24%

Asia

2.76%

Top 10 Holdings

Symbol

Ratio

logo

Cogent Biosciences Inc

8.48%
logo

LivaNova PLC

6.77%
logo

Mirum Pharmaceuticals Inc

4.80%
logo

United Therapeutics Corp

4.78%
logo

Spyre Therapeutics Inc

4.50%
logo

Travere Therapeutics Inc

4.33%
logo

TransMedics Group Inc

4.11%
logo

Guardant Health Inc

4.01%
logo

KalVista Pharmaceuticals Inc

4.01%
logo

Nektar Therapeutics

3.98%

Top 10 Weight 49.77%

44 Total Holdings

Is SPY better than LFSC?
Dividends

No data is currently available

How Much Does LFSC Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy LFSC?
Fund Flows